Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Israel Stocks: Magic Software, D-Pharm, Israel Corp., Prolor

Don't Miss Out —
Follow us on:

May 7 (Bloomberg) -- Israel’s TA-25 index advanced the most since May 3, gaining 0.1 percent to 1,147.72 at the 4:30 p.m. close in Tel Aviv. Investors traded about 1.1 billion shekels ($290 million) of shares and convertible securities, according to bourse data.

The following stocks rose or fell today. Symbols are in parentheses.

D-Pharm Ltd. (DPRM IT) rose 4.8 percent, the biggest advance since April 23, to 0.981 shekel. The biopharmaceutical company reached an initial agreement to buy Thrombotech Ltd., which is developing a peptide that improves the efficiency of stroke medication.

Israel Corp. (ILCO IT) dropped 3.3 percent, the most since Feb. 26, to 2,310 shekels. Standard & Poor’s Maalot cut the rating on the holding company’s unit Zim Integrated Shipping Services Ltd. to ilB from ilBB-.

Magic Software Enterprises Ltd. (MGIC IT) rose 3.3 percent, the most since April 30, to 24.53 shekels. The software technology company said first-quarter profit rose to $4.2 million from $3.1 million a year earlier. Revenue increased to $30 million, beating the $29.3 million estimate of Maxim Group LLC and Rodman & Renshaw LLC, according to data compiled by Bloomberg.

Prolor Biotech Inc. (PBTH IT) jumped 3.8 percent, the largest advance since April 22, to 20.89 shekels. Results from an extended Phase II trial of hGH-CTP human growth hormone showed a single weekly treatment may replace daily injections and was safe.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.